Table 4.4 Reported cases of laboratory-confirmed, hepatitis C (past or present) infection, by sex, race/ethnicity, age group, and positive lab tests — Emerging Infections Program (EIP), Hepatitis Surveillance Demonstration Sites, 2011

Share
Compartir
Category
CO
No. (%)
CT
No. (%)
MN
No. (%)
NM
No. (%)
NY
State
No. (%)
NY
City
No. (%)
OR
No. (%)
San
Francisco
No. (%)
Total
No. (%)
Sex
Female
1030
(35.5)
957
(33.0)
649
(36.0)
884
(31.8)
2467
(35.8)
3146
(36.0)
1639
(36.4)
526
(27.1)
11298
(34.8)
Male
1864
(64.3)
1940
(66.9)
1142
(63.4)
1897
(68.2)
4408
(63.9)
5595
(64.0)
2865
(63.6)
1418
(72.9)
21129
(65.1)
Unknown/Miss
4
(0.1)
1
(0.0)
11
(0.6)
0
(0.0)
23
(0.3)
8
(0.1)
0
(0.0)
0
(0.0)
47
(0.1)
Race/Ethnicity*
AI / AN
24
(0.8)
5
(0.2)
97
(5.4)
46
(1.7)
28
(0.4)
0
(0.0 )
63
(1.4)
13
(0.7)
276
(0.8)
API
16
(0.6)
25
(0.9)
50
(2.8)
3
(0.1)
59
(0.9)
171
(2.0)
46
(1.0)
72
(3.7)
442
(1.4)
Black
143
(4.9)
311
(10.7)
203
(11.3)
12
(0.4)
614
(8.9)
927
(10.6)
105
(2.3)
366
(18.8)
2681
(8.3)
White
992
(34.2)
1222
(42.2)
737
(40.9)
283
(10.2)
2284
(33.1)
667
(7.6)
1964
(43.6)
624
(33.1)
8773
(27.0)
Hispanic
323
(11.2)
506
(17.5)
40
(2.2)
419
(15.1)
434
(6.3)
306
(3.5)
87
(1.9)
148
(7.6)
2263
(7.0)
Other
21
(0.7)
5
(0.2)
9
(0.5)
0
(0.0)
64
(0.9)
287
(3.3)
13
(0.3)
37
(1.9)
436
(1.3)
Unknown / Missing
1379
(47.6)
824
(28.4)
666
(37.0)
2018
(72.6)
3415
(49.5)
6391
(73.1)
2226
(49.4)
684
(35.3)
17603
(54.2)
Age group (yrs)
0-14
11
(0.4)
8
(0.3)
5
(0.3)
10
(0.4)
12
(0.2)
42
(0.5)
5
(0.1)
4
(0.2)
97
(0.3)
15-24
121
(4.2)
143
(4.9)
126
(7.0)
363
(13.1)
416
(6.0)
298
(3.4)
142
(3.2)
34
(1.8)
1643
(5.1)
25-39
613
(21.2)
597
(20.6)
316
(17.5)
923
(33.2)
1337
(19.4)
1629
(18.6)
655
(14.5)
242
(12.5)
6312
(19.4)
40-54
1198
(41.3)
1218
(42.0)
729
(40.5)
938
(33.7)
2352
(34.1)
3035
(34.7)
1980
(44.0)
715
(36.8)
12165
(37.5)
55+
948
(32.7)
932
(32.2)
626
(34.7)
547
(19.7)
2753
(39.9)
3744
(42.8)
1719
(32.8)
948
(48.8)
12217
(37.6)
Missing
7
(0.2)
0
(0.0)
0
(0.0)
0
(0.0)
28
(0.4)
1
(0.0)
3
(0.3)
2
(0.2)
40
(0.1)
Positive Laboratory Tests†
RIBA
279
(9.6)
94
(3.2)
367
(20.4)
U
(U)
746
(10.8)
1117
(12.8)
300
(6.7)
23
(1.2)
2926
(9.0)
HCV RNA
1574
(54.3)
743
(25.6)
1315
(73.0)
U
(U)
3664
(53.1)
4357
(49.8)
2036
(45.2)
1294
(66.6)
14983
(46.1)
Genotype
695
(24.0)
89
(3.1)
626
(34.8)
U
(U)
1494
(22.6)
2582
(29.5)
656
(14.8)
538
(27.7)
6680
(20.6)
Anti-HCV and
s/co ratio
1721
(59.4)
2360
(81.4)
534
(29.6)
U
(U)
3198
(46.4)
7001
(80.0)
1155
(25.6)
1250
(64.3)
17219
(53.0)
Total new
reported cases
2,898 2,898 1,802 2,781 6,898 8,749 4,504 1,944 32,474
Estimated 2010
population
5,116,796 3,580,709 5,344,861 2,082,224 11,220,287 8,244,910 3,871,859 812,826 40,274,472
Rate per 100,000 population
57 81 34 134 61 106 116 239 81

*Categorized in the following order: 1) Hispanic; 2) AI/AN; 3) API; 4) Black; 5) White; 6) Other;
† Cases can be reported with more than one laboratory test result
U=No data available for reporting.